Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PRKC apoptosis WT1 regulator pseudogene (ENSG00000271623)
- Target
- ENSG00000271623
- Molecular classification
- Pseudogene, Other
01
Overview
ENSG00000271623 is a pseudogene annotated as "PRKC apoptosis WT1 regulator pseudogene". Pseudogenes are genomic DNA sequences similar to known genes but typically contain disruptive mutations (frameshifts, premature stop codons) that prevent protein production[3]. Some pseudogenes are transcribed into RNA and may regulate the expression of their parental gene by acting as a microRNA decoy, as shown for PTENP1 and KRAS1P, with implications in cancer biology[1][3]. However, unless experimentally validated, most pseudogenes—including ENSG00000271623—do not have demonstrated biological or therapeutic significance.
- Other names
- PRKC apoptosis WT1 regulator pseudogeneENSG00000271623
02
Mechanism of action
None, as pseudogenes do not encode druggable proteins or active RNAs.
03
Biological functions
Acts as a noncoding RNA decoy in some contexts. Pseudogenes can regulate parental genes by acting as miRNA decoys or by being transcribed into siRNAs with gene regulatory roles—however, this is not generalizable and must be demonstrated for each locus[1][3].No evidence of direct functional roles for this pseudogene specifically.
04
Disease associations
General: Pseudogene expression and copy number variations may modulate cancer pathogenesis indirectly by regulating tumor suppressors or oncogenes[1][3].No disease role established directly for ENSG00000271623.
05
Biomarkers
Other pseudogenes have been studied as biomarkers if their expression modulates parental gene pathways in cancer[1].No evidence for this locus being a biomarker.
Beyond the preview
Go deeper on PRKC apoptosis WT1 regulator pseudogene (ENSG00000271623).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PRKC apoptosis WT1 regulator pseudogene (ENSG00000271623).